Gomes, Nuno
Meireles, Angelina http://orcid.org/0000-0001-9148-2786
Carneiro, Ângela http://orcid.org/0000-0002-3370-7243
Silva, Rufino http://orcid.org/0000-0001-8676-0833
Campos, António http://orcid.org/0000-0003-0490-5889
Duarte, Lilianne http://orcid.org/0000-0003-3953-0730
Flores, Rita http://orcid.org/0000-0002-7523-2418
Marques-Neves, Carlos http://orcid.org/0000-0002-3842-2466
Abreu, Carolina
Amaro, Ana
Beato, João
Amaro, Miguel
Cabral, Diogo
da Luz Cachulo, Maria
Canelas, Joaquim
Carvalho, Rui
Coutinho, André
Correia, Nuno
Falcão, Manuel
Farinha, Cláudia
Figueira, João
Fonseca, Sofia
Fraga, Filipe
Furtado, Maria João
Isidro, Filipe
Lume, Miguel
Macedo, Marta
Marques, Inês
Marques, João Pedro
Mendonça, Luís
Mira, Filipe
Monteiro, Sérgio
Monteiro, Sílvia
Negrão, Pita
Neves, Pedro
Ornelas, Mário
Penas, Susana
Pereira, Sara Silva
Pereira, Sara Vaz
Pessoa, Bernardete
Pires, Isabel
Roque, José
Ruão, Miguel
Santos, Gil Calvão
Silva, Filomena
Teixeira, Carla
Teixeira, Susana
,
Funding for this research was provided by:
novartis portugal
Article History
Received: 8 July 2021
Accepted: 18 December 2021
First Online: 12 February 2022
Declarations
:
: Gomes declares that he has no conflict of interest. Meireles has provided consultancy to Bayer. Carneiro has participated in advisory boards for Alcon, Allergan, Alimera Sciences, Bayer, Novartis and Roche. Silva has participated in advisory boards from Allergan, Alimera Sciences, Bayer, Novartis, Roche, THEA and NovoNordisk. Campos participated in advisory boards for Novartis. Duarte has received financial support from Alimera Sciences. Flores has provided consultancy to Allergan, Alimera Sciences, Bayer and Novartis. Marques-Neves participated in advisory boards from Novartis and received travel grants from Alimera Sciences. The authors have no proprietary or commercial interest in any materials discussed in this article.